Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Gloria Borra

Crizotinib in MET Deregulated or ROS1 Rearranged Pretreated Non-Small-Cell Lung Cancer (METROS): A Phase II, Prospective, Multicentre, Two-Arms Trial

Clinical Cancer Research

Cancer Research

English

Related publications

Alectinib in ALK -Positive, Crizotinib-Resistant, Non-Small-Cell Lung Cancer: A Single-Group, Multicentre, Phase 2 Trial

The Lancet Oncology

English

P2.01-50 Thromboembolism in ROS1 Rearranged Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.01-15 ROS1-Rearranged Non-Small Cell Lung Cancer Is Associated With High Rate of Venous Thromboembolism: Analysis of the METROS Trial

Journal of Thoracic Oncology

Respiratory Medicine

English

Crizotinib Improves Osteoarthritis Symptoms in a ROS1-Fusion Advanced Non–Small Cell Lung Cancer Patient

Journal of Thoracic Oncology

Respiratory Medicine

English

Erlotinib Treatment in Pretreated Patients With Non-Small Cell Lung Cancer: A Phase II Study

Oncology Letters

Cancer Research

English

P1.01-78 the Incidence of Brain Metastases in ROS1-Rearranged Non-Small Cell Lung Cancer at Diagnosis and Following Progression on Crizotinib

Journal of Thoracic Oncology

Respiratory Medicine

English

OA06 Tepotinib in Non-Small Cell Lung Cancer With MET Exon 14-Skipping Mutations or MET Amplification: A Phase 2 Trial in Progress

Journal of Thoracic Oncology

Respiratory Medicine

English

Nitroglycerin as a Radiosensitizer in Non-Small Cell Lung Cancer: Results of a Prospective Imaging-Based Phase II Trial

Clinical and Translational Radiation Oncology

Nuclear Medicine

English

A Phase II Trial of Erlotinib Monotherapy for Pretreated Elderly Patients With Advanced EGFR Wild-Type Non-Small Cell Lung Cancer

BMC Research Notes

Molecular Biology

English